Blog Post

NICE Approval For rTMS Depression Treatment

Chris Morden • January 14, 2016

The National Institute for Health and Care Excellence (NICE) in the UK has now approved rTMS (Repetitive Transcranial Magnetic Stimulation) as an effective and safe method of treating depression for patients in the UK.

NICE Approves rTMS for Depression

The guidelines issued by NICE have not specified or restricted the type of rTMS treatment, which means that practitioners can offer treatment using conventional rTMS – which takes around 40 minutes per session – and/or theta burst, which takes around 5 minutes.

Repetitive Transcranial Magnetic Stimulation is a treatment which uses pulsing magnetic fields to activate brain centers associated with mood.

The treatment has a number of advantages over traditional medication as it is non-invasive. It does not involve surgery, anesthesia or sedation and it does not have the side effects associated with antidepressants.

rTMS has also been shown effective in treating migraine, post-natal depression and pain

Ectron are the UK exclusive distributors of Magventure's rTMS system known as Magvita. This is the only system that has been awarded a CE mark for clinical use.

rTMS treatment is now available from SmartTMS

read more about the approval at: NICE GUIDELINES

< Older Post Newer Post >

Share this post

More Recent News

Tecnobody solutions in NeurotherapyWorx

By Giuliana Kinnerly • January 6, 2025

We are so pleased to see our Tecnobody Solution at the neuro-rehab outpatient centre in Neurotherapy Worx. The centre, based near Wigan, started using the D-Wall at the beginning of the year and went on to include the Prokin 252, WalkerView, and Data Server devices. Clinic owner, Sarah Wilkinson's experience with the advanced motion tracking, analysis, and therapy programs of the D-Wall has led her to adopt additional solutions, such as the Prokin 252 for balance and proprioception, and the Walker View for gait assessment and training. This strategy is designed to motivate patients and supply valuable data to the physiotherapy team, potentially reducing recovery time. See more about Tecnobody devices here: https://www.ectron.co.uk/tecnobody

Celebrating 15 Years of Ectron

By Giuliana Kinnerly • August 5, 2024

We are so excited to share with you that this year marks the 15 year anniversary of Ectron and the services to neurological rehabilitation technology. Ectron has been recognised as the UK leader in the implementation of neurological rehabilitation robotic and sensor-based technology. As these new devices entered the UK market, it became a period of change that required leadership from key clinicians and Ectron is proud to have supported them in developing their business cases and new work practices. Ectron are proud to have worked with some of the UK’s leading and pioneering Neurological Rehabilitation Centres such as: Hospital of Neurology and Neurosurgery MOTIONrehab's Intensive Neurological Rehabilitation Centres Hobbs Rehabilitation Stoke Mandeville Spinal Injury Unit

Robotic-assisted rehabilitation protocol for upper limb treatment in stroke: New Research Study

By Lucille Watts • May 29, 2024

Researchers from IRCCS Fondazione Don Carlo Gnocchi ONLUS in Italy, evaluate the effectiveness of a customised robotic upper limb rehabilitation protocol for the treatment of stroke patients.